ClinicalTrials.Veeva

Menu

Characterization of Placental Diffusion

H

Hillel Yaffe Medical Center

Status

Enrolling

Conditions

Pregnancy in Diabetic
Placenta Diseases

Treatments

Diagnostic Test: DW-MRI

Study type

Interventional

Funder types

Other

Identifiers

NCT06992245
0042-22-HYMC

Details and patient eligibility

About

DW-MRI Allows a quantitative comparison of diffusion as an expression of tissue hypoxia. The investigators aim is to compare changes in placental diffusion in pregnant women with uncontrolled diabetes compared to healthy pregnant women using DW-MRI.

The investigators hypothesize that placentas of diabetic mothers will show lower diffusion / perfusion compared to placentas of healthy women.

Full description

In highly uncontrolled diabetes there is an increased risk of intrauterine fetal death. The mechanism of fetal death is unknown and unpredictable. One of the theories points to hypoxia as a precursor to the death of the fetus in the womb. If the researchers succeed in predicting changes in the placenta with the help of MRI, it may be possible to understand the mechanism of fetal damage as well as in the future to develop a protocol for predicting pregnancies prone to fetal death in the womb.

Enrollment

40 estimated patients

Sex

Female

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women with PGAM (Pre-gestational diabetes) diagnosed before 20 weeks of pregnancy
  • Women with GDMA (Gestational diabetes) diagnosed by OGTT after 20 weeks of pregnancy

Exclusion criteria

  • pregnant women with placental hypoxia disease related in the past
  • pregnant women with placental hypoxia disease related in the present
  • non-singleton pregnancy
  • women in active labor or rupture of membrane
  • smoking women
  • suspicion of placenta accreta

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Pregnant women with gestational diabetes mellitus
Experimental group
Description:
3Th trimester pregnant women with gestational diabetes mellitus
Treatment:
Diagnostic Test: DW-MRI
Low risk pregnant women
Active Comparator group
Description:
3Th trimester pregnant women with unknown diseases (low risk factors)
Treatment:
Diagnostic Test: DW-MRI

Trial contacts and locations

1

Loading...

Central trial contact

Moran Rotman, MD; Rinat Gabbay-Benziv, Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems